13 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Structure-Affinity Relationship Analysis of Selective FKBP51 Ligands.
Max Planck Institute of Psychiatry
Evaluation of synthetic FK506 analogues as ligands for the FK506-binding proteins 51 and 52.
Max Planck Institute of Psychiatry
Exploration of pipecolate sulfonamides as binders of the FK506-binding proteins 51 and 52.
Max Planck Institute of Psychiatry
Synthesis and evaluation of Glypsi(PO(2)R-N)Pro-containing pseudopeptides as novel inhibitors of the human cyclophilin hCyp-18.
Departement D'Ingenierie Et D'Etudes Des Proteines
Design of a Gag pentapeptide analogue that binds human cyclophilin A more efficiently than the entire capsid protein: new insights for the development of novel anti-HIV-1 drugs.
Departement D'Ingenierie Et D'Etudes Des Proteines
Structure-Based Discovery of a New Selectivity-Enabling Motif for the FK506-Binding Protein 51.
Technical University Darmstadt
Peptidyl-Proline Isomerases (PPIases): Targets for Natural Products and Natural Product-Inspired Compounds.
University of Michigan
Structure-Based Design of High-Affinity Macrocyclic FKBP51 Inhibitors.
Technical University Darmstadt
Bioinspired Hybrid Fluorescent Ligands for the FK1 Domain of FKBP52.
Paris-Sud University
Synthesis and cytotoxic evaluation of cycloheximide derivatives as potential inhibitors of FKBP12 with neuroregenerative properties.
Max-Planck Research Unit
Chemogenomic Profiling of Human and Microbial FK506-Binding Proteins.
Max Planck Institute of Psychiatry
Substituted 1,1′-biphenyl compounds, analogues thereof, and methods using same
Arbutus Biopharma